AZ SB1214

Authorizes licensed health providers in Arizona to perform stem cell and regenerative therapies not approved by the FDA, provided they complete nationally recognized continuing education training and obtain written informed consent from patients

Requires all stem cells, exosomes, and biologic materials be sourced exclusively from facilities registered with the FDA or certified/accredited by organizations including the National Marrow Donor Program, American Association of Tissue Banks, or American Academy of Stem Cell Medicine

Mandates specific advertising disclosures in the largest type size used, stating the therapy is not FDA-approved and encouraging patients to consult their primary care provider

Requires providers to report serious adverse events to their health profession regulatory board within 15 calendar days and to the therapy supplier

Allows patients who receive treatment violating these requirements to bring civil action for $10,000 per violation plus attorney fees and costs